Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

Ajanta Pharma Announces the Launch of Amlodipine + Olmesartan Medoxomil Tablets

Ajanta Pharma USA Inc.
Posted on: 02 Nov 16

PR Newswire

BRIDGEWATER, N.J., Nov. 2, 2016

BRIDGEWATER, N.J., Nov. 2, 2016 /PRNewswire/ -- Ajanta Pharma USA Inc., a wholly owned subsidiary of Ajanta Pharma Ltd, India, announces today the launch of Amlodipine + Olmesartan Medoxomil Tablets, (5mg+20mg, 5mg+40mg, 10mg+20mg, 10mg+40mg), a bioequivalent generic version of Azor®1 Tablets into the US market.

Amlodipine + Olmesartan Medoxomil Tablets is part of an ever-growing portfolio of products that Ajanta has developed for the US market. In total, Ajanta has 29 Abbreviated New Drug Applications (ANDAs) of which it has 16 final ANDA approvals; 2 tentative approvals; and 11 ANDAs under review with the United States Food & Drug Administration.

About Ajanta Pharma

Ajanta Pharma Limited is a specialty pharmaceutical formulation company with global headquarters in Mumbai, India. Over 6,000 employees are engaged in developing, manufacturing, and marketing quality, finished pharmaceuticals across 30+ countries.

For the financial year ended March 31, 2016, Ajanta's consolidated revenue stood at $261 million and net profit of $61 million. For the last five years, Ajanta has posted healthy performance with its consolidated revenue growing at 26% CAGR and net profit at 51% CAGR.

For more details about Ajanta Pharma USA Inc., please visit us at www.ajantapharmausa.com.

1 Azor® is a registered trademark of Daiichi Sankyo Inc .

Photo - http://photos.prnewswire.com/prnh/20161102/435278

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/ajanta-pharma-announces-the-launch-of-amlodipine--olmesartan-medoxomil-tablets-300355868.html

SOURCE Ajanta Pharma USA Inc.

PR Newswire
www.prnewswire.com

Last updated on: 02/11/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.